Drug intelligence / Profile preview

bone marrow mesenchymal stem cell-derived small extracellular vesicles

Development stage
Unknown
Lead developer
Mahidol University
Modality
Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Administration
Ophthalmic
01

Overview

This is an investigational cell-free biologic therapy developed by Mahidol University's Faculty of Medicine Siriraj Hospital for the treatment of retinitis pigmentosa. The therapy consists of Good Manufacturing Practice (GMP)-compliant small extracellular vesicles (sEVs) harvested from bone marrow-derived mesenchymal stem cells (BM-MSCs). Administered via a single intravitreal injection, these vesicles are designed to deliver the therapeutic benefits of MSCs—specifically anti-inflammatory, neuroprotective, and anti-apoptotic effects—without the risks associated with live cell transplantation, such as vitreoretinal traction or immune rejection. The product is currently being evaluated in a Phase 1/2 clinical trial to assess its safety and efficacy in patients with this progressive inherited retinal disease.

Other names
BM-MSC-derived sEVsGMP-compliant BM-MSC-derived sEVsMSC-sEVsbone marrow mesenchymal stem cell-derived sEVs

Beyond the preview

Go deeper on bone marrow mesenchymal stem cell-derived small extracellular vesicles.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on bone marrow mesenchymal stem cell-derived small extracellular vesicles.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call